BioSpace News Archive

Katena Products, Inc. (Katena) a leading global provider of premium ophthalmic instruments, biologics, and devices to hospitals, surgical centers, and ophthalmic and optometric offices announces the purchase of ASICO, LLC (ASICO).

Harrow Health, Inc. (NASDAQ: HROW), an ophthalmic-focused healthcare company, today announced certain preliminary unaudited financial results for the first quarter ended March 31, 2021.

A major scientific breakthrough in the development of novel cancer therapeutics targeting the Notch pathway has been published online ahead of print in the journal Cancer Research.

First patient dosed at third dose level in ongoing trial of RGX-121, a one-time gene therapy for MPS II; total of nine patients have been dosed at four leading clinical centers in the U.S. and Brazil

Universal Health Services, Inc. (NYSE: UHS) announced today that it will report results for its first quarter ended March 31, 2021 after the market closes on Monday, April 26, 2021.

Aura Biosciences Announces Publication of Data in Cancer Immunology Research , Supporting the Immune Mediated Mechanism of Action of the Virus-Like Drug Conjugate (VDC) Technology Platform with Broad Application in Cancer Treatment - Results Support VDCs induction of Pro Immunogenic Cell Death and the Generation of Long Lasting Adaptive Anti-Tumor Immunity -

Remains on Track to Dose First Subjects in Q2 2021.

Newly Created Holloway Family Fund Plans to Donate $1M Annually for 10 Years for Research into Frontotemporal Degeneration, the Most Common Dementia Under 60

Medvantx, pharmacy services provider, announced the appointment of Micah Benford to chief pharmacy officer of Medvantx Pharmacy Services.